ANRO

ANRO

USD

Alto Neuroscience Inc. Common Stock

$11.500-0.480 (-4.007%)

Real-time Price

Healthcare
Biotechnology
United States

Price Chart

Loading Chart...

Key Metrics

Market Metrics
Company Fundamentals
Trading Stats

Market Metrics

Open

$11.980

High

$11.810

Low

$10.200

Volume

0.08M

Company Fundamentals

Market Cap

355.5M

Industry

Biotechnology

Country

United States

Trading Stats

Avg Volume

1.51M

Exchange

NYQ

Currency

USD

52-Week Range

Low $1.6Current $11.500High $15.18

Related News

BusinessWire

Alto Neuroscience to Participate in Upcoming Investor Conferences

Alto Neuroscience, Inc. ("Alto") (NYSE:ANRO) a clinical-stage biopharmaceutical company focused on the development of novel precision medicines for neuropsychiatric disorders, today announced that members of the

View more
Alto Neuroscience to Participate in Upcoming Investor Conferences
Analyst Upgrades

HC Wainwright & Co. Maintains Buy on Alto Neuroscience, Raises Price Target to $50

HC Wainwright & Co. analyst Patrick R. Trucchio maintains Alto Neuroscience with a Buy and raises the price target from $10 to $50.

View more
HC Wainwright & Co. Maintains Buy on Alto Neuroscience, Raises Price Target to $50